Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin add-on to Tamsulosin for OAB in BPH men
NCT00771394Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2008
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Oct 2008; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00771394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771394.